"Epclusa, a combination of sofosbuvir and the new drug velpatasvir, has been approved by the FDA to treat 6 major strains of the virus. 99 percent cure rate. You can read more about it at https://www.nlm.nih.gov/medlineplus/news/fullstory..."
Are you sure you want to delete your ?
You will no longer be able to add new data to this tracker.